Takaisin Tulosta

Familiaalinen kombinoitunut hyperlipidemia (FKH)

Lisätietoa aiheesta
Niina Matikainen
18.12.2017

Kirjallisuutta

  1. Goldstein JL, Schrott HG, Hazzard WR ym. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-68 «PMID: 4718953»PubMed
  2. Nikkilä EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet 1973;1:954-9 «PMID: 4121585»PubMed
  3. Porkka KV, Nuotio I, Pajukanta P ym. Phenotype expression in familial combined hyperlipidemia. Atherosclerosis 1997;133:245-53 «PMID: 9298685»PubMed
  4. Voors-Pette C, de Bruin TW. Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity. Atherosclerosis 2001;157:481-9 «PMID: 11472750»PubMed
  5. Genest JJ Jr, Martin-Munley SS, McNamara JR ym. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992;85:2025-33 «PMID: 1534286»PubMed
  6. Veerkamp MJ, de Graaf J, Bredie SJ ym. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol 2002;22:274-82 «PMID: 11834528»PubMed
  7. Brahm AJ, Hegele RA. Combined hyperlipidemia: familial but not (usually) monogenic. Curr Opin Lipidol 2016;27:131-40 «PMID: 26709473»PubMed
  8. Catapano AL, Graham I, De Backer G ym. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016;37:2999-3058 «PMID: 27567407»PubMed
  9. Ripatti P, Rämö JT, Söderlund S ym. The Contribution of GWAS Loci in Familial Dyslipidemias. PLoS Genet 2016;12:e1006078 «PMID: 27227539»PubMed
  10. Hegele RA, Ban MR, Cao H ym. Targeted next-generation sequencing in monogenic dyslipidemias. Curr Opin Lipidol 2015;26:103-13 «PMID: 25692347»PubMed